SCHEMBL2650722

SCHEMBL2650722

N#Cc1cc(F)ccc1-c1c(F)ccc(N)c1F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.43
ALDH1A1 P00352 1/20 0.40
GABRA1 P14867 9/20 0.35
GABRG2 P18507 9/20 0.35
GABRB3 P28472 9/20 0.35
GABRA5 P31644 7/20 0.35
GABRA3 P34903 7/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
GABRA2 P47869 4/20 0.34
RORC P51449 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
KHK P50053 1/20 0.32
TRPV4 Q9HBA0 1/20 0.32
EGLN2 Q96KS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2650437 0.81 GABRA1 (0.34) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2651557 0.78 BCAT1 (0.37) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL30262619 0.75 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2AKHK
SCHEMBL168901 0.75 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2AKHK
SCHEMBL21116203 0.75 USP8 (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2658458 0.74 LPL (0.35) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2650000 0.74 GABRA1 (0.42) ALDH1A1GABRA1GABRG2GABRB3GABRA5
SCHEMBL14744345 0.73 RORC (0.45) ALDH1A1ADORA2AADORA1RORCKDM4E
SCHEMBL2651420 0.72 CUL4A (0.39) KDM1AGABRA1GABRG2GABRB3GABRA5
SCHEMBL74807 0.71 TRPV4 (0.46) ALDH1A1TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005431-B2 Imidazo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. 2006-02-28 US disclosed
US-20050165023-A1 Imidazo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. (GB) 2005-07-28 US disclosed
EP-1381606-B1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME (GB) 2005-07-20 EP disclosed
US-6900215-B2 For therapy of disorders of central nervous system, including anxiety, convulsions and cognitive disorders MERCK SHARP & DOHME LTD. (GB) 2005-05-31 US disclosed
EP-1504007-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LTD. (GB) 2005-02-09 EP disclosed
WO-2003093272-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2003-11-13 WO disclosed
US-20020193385-A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors MERCK SHARP & DOHME (UK) LIMITED (GB) 2002-12-19 US disclosed
WO-2002074772-A1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2002-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193385-A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors GABRA3, GABRA1, GABRA2 KDM1A 2899/4885ALDH1A1 404/4885GABRA1 2/4885
US-20050165023-A1 Imidazo-triazine derivatives as ligands for gaba receptors GABRA5, GABRA3, GABRA2 KDM1A 3418/4885ALDH1A1 803/4885GABRA1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.